Global Institute Of Stem Cell Therapy And Research

Regenerative Medicine and Healthcare Risks: Risk Group Dialogue with GIOSTAR CEO Mr. Deven Patel

Regenerative Medicine and Healthcare Risks: Risk Group Dialogue with Deven Patel

While a big-data revolution is under way in health care, there is also another silent revolution brewing in healthcare industry in the form of Regenerative Medicine.

In this session of Risk Roundup, Risk Group discusses Regenerative Medicine and Healthcare with GIOSTAR CEO Mr. Deven Patel, CEO, President & Cofounder at Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A.

Make An Enquiry

We are here to help you

Call Us +91-7043008890
WordPress Video Lightbox